Quantum Biopharma Ltd. Files August 2025 6-K Report

Ticker: QNTM · Form: 6-K · Filed: Aug 4, 2025 · CIK: 1771885

Quantum Biopharma Ltd. 6-K Filing Summary
FieldDetail
CompanyQuantum Biopharma Ltd. (QNTM)
Form Type6-K
Filed DateAug 4, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: reporting, sec-filing, company-update

TL;DR

Quantum Biopharma (fka FSD Pharma) filed their August 6-K, confirming 20-F annual report submission.

AI Summary

Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on August 4, 2025, reporting for the month of August 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, is in the pharmaceutical preparations industry. This filing indicates they are submitting their annual reports under Form 20-F.

Why It Matters

This filing provides an update on Quantum Biopharma's reporting status and confirms their adherence to SEC regulations for foreign private issuers, which is crucial for investor transparency.

Risk Assessment

Risk Level: low — This is a routine reporting form (6-K) that doesn't disclose new material financial or operational information, making the immediate risk low.

Key Players & Entities

  • Quantum Biopharma Ltd. (company) — Filer of the report
  • FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
  • August 4, 2025 (date) — Filing date
  • Toronto, Canada (location) — Company headquarters
  • Form 6-K (document) — Type of SEC filing
  • Form 20-F (document) — Annual report form

FAQ

What is the primary purpose of this Form 6-K filing?

The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of August 2025.

What was Quantum Biopharma Ltd. formerly known as?

Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc., with a date of name change on March 27, 2019.

Where is Quantum Biopharma Ltd. headquartered?

Quantum Biopharma Ltd. is headquartered at 55 University Avenue, Suite 1003, Toronto, Ontario, M5J 2H7, Canada.

Which annual report form does Quantum Biopharma Ltd. indicate it files?

Quantum Biopharma Ltd. indicates by check mark that it files annual reports under cover of Form 20-F.

What is the SIC code for Quantum Biopharma Ltd.?

The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on August 4, 2025 regarding Quantum Biopharma Ltd. (QNTM).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.